[Federal Register Volume 62, Number 55 (Friday, March 21, 1997)]
[Notices]
[Page 13660]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 97-7129]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Amended Notice of Meeting
Notice is hereby given of a change in the meeting of the Advisory
Committee on Blood Safety and Availability, Department of Health and
Human Services, March 20-21, 1997, which was published in the Federal
Register on March 3, 1997 (62 FR 9441).
This meeting will be held on April 24-25, 1997, instead of the
previously stated March 20-21. The Advisory meeting remains at the same
time and place, 8:30 a.m., National Institutes of Health, Warren G.
Magnuson Clinical Center, Jack Masur Auditorium, 9000 Rockville Pike,
Bethesda, Maryland 20892. As previously stated, this meeting will be
entirely open to the public.
On April 24, the Committee will discuss hepatitis C virus (HCV)
infection, its occurrence following blood transfusion, other
epidemiology of HCV infection and appropriate ways of approaching the
public health aspects of this infection. On April 25, the Committee
will address multiple aspects of the theoretical possibility that
Creutzfeldt-Jakob disease (CJD) can be transmitted by blood
transfusion. For each topic, a time will be set aside for the public to
comment. Prospective speakers should notify the Executive Secretary for
this meeting of their wish to present and should plan for no more than
5 minutes of comments.
CONTACT: Paul R. McCurdy, M.D., Acting Executive Secretary, Advisory
Committee on Blood Safety and Availability, Director, Blood Resources
Program, DBDR-MSC-7950, NHLBI, NIH, Bethesda, Maryland 20892-7950.
Phone: 301/435-0065; Fax 301/480-1060; E-Mail: [email protected].
Dated: March 17, 1997.
LaVerne Y. Stringfield,
Committee Management Officer, NIH.
[FR Doc. 97-7129 Filed 3-20-97; 8:45 am]
BILLING CODE 4140-01-M